ESR1 c.1625A>C ;(p.E542A)

Variant ID: 6-152419938-A-C

NM_000125.3(ESR1):c.1625A>C;(p.E542A)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


The prognostic effects of somatic mutations in ER-positive breast cancer.

Nature Communications
Griffith, Obi L OL; Spies, Nicholas C NC; Anurag, Meenakshi M; Griffith, Malachi M; Luo, Jingqin J; Tu, Dongsheng D; Yeo, Belinda B; Kunisaki, Jason J; Miller, Christopher A CA; Krysiak, Kilannin K; Hundal, Jasreet J; Ainscough, Benjamin J BJ; Skidmore, Zachary L ZL; Campbell, Katie K; Kumar, Runjun R; Fronick, Catrina C; Cook, Lisa L; Snider, Jacqueline E JE; Davies, Sherri S; Kavuri, Shyam M SM; Chang, Eric C EC; Magrini, Vincent V; Larson, David E DE; Fulton, Robert S RS; Liu, Shuzhen S; Leung, Samuel S; Voduc, David D; Bose, Ron R; Dowsett, Mitch M; Wilson, Richard K RK; Nielsen, Torsten O TO; Mardis, Elaine R ER; Ellis, Matthew J MJ
Publication Date: 2018-09-04

Variant appearance in text: ESR1: E542A
PubMed Link: 30181556
Variant Present in the following documents:
  • 41467_2018_5914_MOESM1_ESM.pdf
View BVdb publication page



Functional characterization of somatic mutations in cancer using network-based inference of protein activity.

Nature Genetics
Alvarez, Mariano J MJ; Shen, Yao Y; Giorgi, Federico M FM; Lachmann, Alexander A; Ding, B Belinda BB; Ye, B Hilda BH; Califano, Andrea A
Publication Date: 2016-08

Variant appearance in text: ESR1: E542A
PubMed Link: 27322546
Variant Present in the following documents:
  • NIHMS789775-supplement-1.pdf
View BVdb publication page